Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A retrospective cohort study of response and survival in pediatric patients with relapsed and refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy) treated with contemporary salvage therapy
Protocol ID
T2018-001
Disease (Sub Disease)
Leukaemia (ALL)
Lymphoma (LLy)
Lymphoma (LLy)
Diagnosis Stage
Relapsed/refractory
Location
NSW
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 years
| Study Title | A retrospective cohort study of response and survival in pediatric patients with relapsed and refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy) treated with contemporary salvage therapy |
|---|---|
| Protocol ID | T2018-001 |
| Disease (Sub Disease) | Leukaemia (ALL) Lymphoma (LLy) |
| Diagnosis Stage | Relapsed/refractory |
| Location | NSW |
| Sponsor | Therapeutic Advances in Childhood Leukemia Consortium |
| Trial Status | Open |
| Trial Open Date | 01/01/2022 |
| Sites | The Children's Hospital at Westmead |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | up to 21 years |